Скачать или смотреть Do not buy Mirum Pharmaceuticals stock before seeing this video!📈 (MIRM Stock Analysis)

🔥 Free Telegram Channel:
https://t.me/denisstelmak

💵Best place to buy and hold PRE IPO:
https://t.me/preipostorebot

❤️ YouTube paid subscription:
   / @denisstelmak  

💸 Patreon paid subscription:
  / stelmak  

❤️ Please help me to grow this channel and share links on your social platform. Don’t forget to subscribe ➡️ https://bit.ly/2JVXmZJ and smash the like button 👍👍👍

I am helping people to buy PRE IPO. Just write to me via email: (channel page → about) or Instagram: @stelmakdv

I use two brokers to trade stocks:
💵1) https://bit.ly/2VlMtFO (Support all countries, low commissions)
💵2) https://bit.ly/39XBKXf (Support all countries, commission FREE!)
They are both SIPC protected up to $500,000

I read all comments, feel free to ask questions and publish your thoughts about the stock market. Sometimes the comments are extremely helpful!

I speak too slow? Change the playback speed to 1.5-2.0

📹 My old Camera: https://amzn.to/2VBXjrg (all videos before 10/15/2020)
📹 My new Camera: https://amzn.to/3kborZ6 (all videos after 10/15/2020)
🎤 My Microphone: https://amzn.to/2VELpNn
💻 My Recording and editing software: https://amzn.to/373gD6U

I recommend you watch these videos:
🥇 Side Hustle Ideas:
   • TOP 5 SIDE HUSTLE IDEAS 2020!💰  

🥈 China 2021-2025 Plan:
   • China 2021-2025 Plan.📈 What to expect from...  

🥉 Venture investments:
   • Venture investments!📈 How much money you c...  

🏅 Investing vs Speculating:
   • Investing vs Speculating!📈 What is the dif...  

🏅 Inflation rate and interest rate:
   • They have to raise INTEREST RATE!📈 Or we w...  

☢DISCLAIMER: I recommend you always do your research. Never invest more than 5% of your portfolio in one stock. I am not 100% right all the time. You could lose money following my advice. Some links may be affiliated. Video content could contain paid promotions.☢

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.